187 filings
10-Q
2024 Q1
MNMD
Mind Medicine Inc
Quarterly report
8 May 24
4:15pm
8-K
MNMD
Mind Medicine Inc
8 May 24
MindMed Reports First Quarter 2024 Financial Results and Business Updates
4:10pm
424B3
MNMD
Mind Medicine Inc
30 Apr 24
Prospectus supplement
9:18am
424B3
MNMD
Mind Medicine Inc
30 Apr 24
Prospectus supplement
8:08am
EFFECT
MNMD
Mind Medicine Inc
30 Apr 24
Notice of effectiveness
12:15am
ARS
utefz mengah0v
26 Apr 24
Annual report to shareholders
8:04am
DEFA14A
rnia0bw xzzr32v
26 Apr 24
Additional proxy soliciting materials
8:02am
8-K
g4sqf8 ugr
1 Apr 24
MindMed Announces Voluntary Delisting from Cboe Canada
5:03pm
D
s4tbxj a4ah1bphfqk
18 Mar 24
$75.00 mm in equity, sold $75.00 mm, 2 investors
5:11pm
8-K
8go87zng2
11 Mar 24
Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement
8:32am
424B5
xtfis30qzps74 4wpu8u
7 Mar 24
Prospectus supplement for primary offering
9:43pm
8-K
yqug5 657
7 Mar 24
Regulation FD Disclosure
8:19am
S-3MEF
1tsmwwxc
7 Mar 24
Registration of additional securities for an S-3
7:09am
8-K
bb09v2 3sndr
7 Mar 24
Mindmed Receives Fda Breakthrough Therapy Designation
6:56am
8-K
kl9carx
28 Feb 24
MindMed Reports 2023 Financial Results and Business Updates
7:15am
8-K
cw2s111y
8 Jan 24
MindMed Announces Business Update and Anticipated Milestones for 2024
8:00am
8-K
r7kbm rsy
14 Dec 23
MindMed Announces Positive Topline Results from Phase 2b Trial of MM-120
7:57am